Since these early studies, mounting evidence demonstrates that HDAC inhibitors are efficacious in models of pathological cardiac remodeling and heart failure, yet the molecular mechanisms of HDAC actions are continually being explored. The gene discussed is HDAC9; the disease is heart failure.